Literature DB >> 7931447

Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation.

S Neilson1, I Robinson, A Alperovitch.   

Abstract

Gompertzian analysis is a statistical technique which has been successfully applied to the analysis of amyotrophic lateral sclerosis (ALS) mortality in England and Wales, Japan and the United States. This paper analyses the consistent trend of rising ALS mortality in France over the years 1968-1990, a period during which crude mortality rose from 400 deaths in 1968 to 950 deaths in 1990. The findings indicate that age-specific mortality rates have risen at ages older than 54 years for men and 53 years for women and decreased slightly at younger ages. The evolving ALS mortality pattern is attributable to changing inter-disease competition resulting from the increased life expectancy of the French population, rather than to changing environmental aetiopathogenic factors or to substantial artefact effects.

Entities:  

Mesh:

Year:  1994        PMID: 7931447     DOI: 10.1007/bf00900964

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Longitudinal Gompertzian analysis of amyotrophic lateral sclerosis mortality in the U.S., 1977-1986: evidence for an inherently susceptible population subset.

Authors:  J E Riggs
Journal:  Mech Ageing Dev       Date:  1990-09       Impact factor: 5.432

Review 2.  Risk factors in amyotrophic lateral sclerosis.

Authors:  J F Kurtzke
Journal:  Adv Neurol       Date:  1991

3.  Rising mortality from motoneuron disease.

Authors:  T P Flaten
Journal:  Lancet       Date:  1989-05-06       Impact factor: 79.321

4.  Amyotrophic lateral sclerosis in Sweden 1970-83 and solvent exposure.

Authors:  L G Gunnarsson; G Lindberg
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

5.  Mexican "resistance" to amyotrophic lateral sclerosis.

Authors:  L Olivares; E S Estéban; M Alter
Journal:  Arch Neurol       Date:  1972-11

6.  ALS in Rochester, Minnesota, 1925-1977.

Authors:  S M Juergens; L T Kurland; H Okazaki; D W Mulder
Journal:  Neurology       Date:  1980-05       Impact factor: 9.910

7.  Rising mortality from motoneuron disease in the USA, 1962-84.

Authors:  D E Lilienfeld; E Chan; J Ehland; J Godbold; P J Landrigan; G Marsh; D P Perl
Journal:  Lancet       Date:  1989-04-01       Impact factor: 79.321

8.  Motor neuron disease in England and Wales, 1959-1979.

Authors:  J Buckley; C Warlow; P Smith; D Hilton-Jones; S Irvine; J R Tew
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-03       Impact factor: 10.154

9.  Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.

Authors:  T M Li; M Swash; E Alberman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

Review 10.  Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'.

Authors:  Thomas B L Kirkwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-19       Impact factor: 6.237

View more
  8 in total

Review 1.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

2.  Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.

Authors:  Paul H Gordon; Fanny Artaud; Albertine Aouba; Françoise Laurent; Vincent Meininger; Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-06-15       Impact factor: 8.082

3.  Epidemiology of amyotrophic lateral sclerosis in Southern Germany.

Authors:  Angela Rosenbohm; Raphael S Peter; Siegfried Erhardt; Dorothée Lulé; Dietrich Rothenbacher; Albert C Ludolph; Gabriele Nagel
Journal:  J Neurol       Date:  2017-02-20       Impact factor: 4.849

Review 4.  The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey.

Authors:  Martin R Turner; Michael Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-02       Impact factor: 10.154

5.  Prevalence and incidence of amyotrophic lateral sclerosis in Japan.

Authors:  Yuriko Doi; Naoki Atsuta; Gen Sobue; Mitsuya Morita; Imaharu Nakano
Journal:  J Epidemiol       Date:  2014-08-23       Impact factor: 3.211

Review 6.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

7.  Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany--completeness of the ALS registry Swabia.

Authors:  Hatice Uenal; Angela Rosenbohm; Johannes Kufeldt; Patrick Weydt; Katharina Goder; Albert Ludolph; Dietrich Rothenbacher; Gabriele Nagel
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

8.  A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.

Authors:  Mark A S Laidlaw; Dominic B Rowe; Andrew S Ball; Howard W Mielke
Journal:  Int J Environ Res Public Health       Date:  2015-12-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.